Equine H-FABP antibody and antigen (recombinant protein)

Diagnostic anti-Equine H-FABP antibodies pairs and antigen for animal health (animal Equine/Horse myocardial injury) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-H-FABP-Ag01 Recombinant Equine H-FABP protein 3090
GMP-EQU-H-FABP-Ab01 Anti-Equine H-FABP mouse monoclonal antibody (mAb) 1953
GMP-EQU-H-FABP-Ab02 Anti-Equine H-FABP mouse monoclonal antibody (mAb) 1953
GMP-EQU-H-FABP-Ab03 Anti-Equine H-FABP human monoclonal antibody (mAb) 1953
GMP-EQU-H-FABP-Ab04 Anti-Equine H-FABP human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-H-FABP-Ag01
Product Name Recombinant Equine H-FABP protein
Target/Biomarker Equine Heart-type Fatty Acid-Binding Protein (H-FABP)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine Heart-type Fatty Acid-Binding Protein antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in H-FABP level test of animal Equine/Horse with myocardial injury.
Tag His
Products description Recombinant Equine H-FABP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-H-FABP-Ab01, GMP-EQU-H-FABP-Ab02
Product Name Anti-Equine H-FABP mouse monoclonal antibody (mAb)
Target/Biomarker Equine Heart-type Fatty Acid-Binding Protein (H-FABP)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine Heart-type Fatty Acid-Binding Protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-H-FABP antibodies in H-FABP level test of animal Equine/Horse with myocardial injury.
Tag mFc
Products description Anti-Equine H-FABP mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-H-FABP antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-H-FABP-Ab03, GMP-EQU-H-FABP-Ab04
Product Name Anti-Equine H-FABP human monoclonal antibody (mAb)
Target/Biomarker Equine Heart-type Fatty Acid-Binding Protein (H-FABP)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine Heart-type Fatty Acid-Binding Protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-H-FABP antibodies in H-FABP level test of animal Equine/Horse with myocardial injury.
Tag hFc
Products description Anti-Equine H-FABP human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-H-FABP antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    H-FABP, or Heart-Fatty Acid Binding Protein, emerges as a pivotal biomarker in the intricate realm of equine (horse) physiology. This unassuming yet indispensable protein finds its primary expression within the heart muscle, or cardiomyocytes, where it orchestrates the regulation of fatty acid metabolism. Structurally, H-FABP is a cytoplasmic protein adorned with a distinct binding pocket that enables it to transport and facilitate the utilization of fatty acids—a fundamental energy source—within the equine cardiac muscle cells. The exclusive residence of H-FABP within the equine heart underscores its crucial role in assessing cardiac health. Under normal physiological circumstances, H-FABP levels in the bloodstream of horses remain relatively low. However, its concentration can surge significantly in response to cardiac stress or injury, rendering it a highly sensitive and specific diagnostic tool for veterinarians and a source of invaluable insights for equine enthusiasts. H-FABP's functional significance within the heart extends beyond its metabolic role. It is when the equine heart faces challenges that the true importance of H-FABP as a biomarker shines. In scenarios where cardiac ischemia or infarction occurs, such as a heart attack, a segment of the heart muscle becomes deprived of oxygen and nutrients due to a blocked artery. It is during this ischemic injury that H-FABP is released into the bloodstream. Consequently, elevated levels of H-FABP in a horse's blood can serve as an early indicator of myocardial damage, often preceding clinical symptoms. The rapid identification of such cardiac issues allows for prompt medical intervention, potentially limiting the extent of cardiac damage and enhancing the likelihood of a positive outcome.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment